OPKO Health, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
OPKO Health, Inc. (OPK) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $1.55 billion as of 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-05-03
- 2023-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.55B.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.56B.
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.63B.
- 2022-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.72B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2023-03-31 | $1.55B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.56B 10-Q · filed 2023-05-03 | |
| 2022-09-30 | $1.63B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.72B 10-Q · filed 2022-11-08 | |
| 2022-03-31 | $1.61B 10-Q · filed 2023-05-03 | |
| 2021-12-31 | $1.69B 10-Q · filed 2023-05-03 | |
| 2021-09-30 | $1.77B 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.74B 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.70B 10-Q · filed 2022-08-04 | |
| 2020-12-31 | $1.67B 10-K · filed 2023-02-27 | |
| 2020-09-30 | $1.62B 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.59B 10-Q · filed 2021-10-28 | |
| 2020-03-31 | $1.55B 10-Q · filed 2021-07-29 | |
| 2019-12-31 | $1.61B 10-K · filed 2023-02-27 | |
| 2019-09-30 | $1.64B 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $1.71B 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $1.76B 10-Q · filed 2020-07-31 | |
| 2018-12-31 | $1.79B 10-Q · filed 2020-10-29 | |
| 2018-09-30 | $1.78B 10-Q · filed 2019-11-05 | $1.79B 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.80B 10-Q · filed 2019-11-05 | $1.81B 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.81B 10-Q · filed 2019-08-07 | $1.82B 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.84B 10-Q · filed 2019-11-05 | $1.89B 10-K · filed 2018-03-01 |
| 2017-09-30 | $2.09B 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $2.11B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $2.11B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.05B 10-K · filed 2019-03-01 | $2.09B 10-K · filed 2017-03-01 |
| 2016-09-30 | $2.11B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.02B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $2.00B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $1.96B 10-K · filed 2019-03-01 | $1.98B 10-K · filed 2016-02-29 |
| 2015-09-30 | $1.97B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $826.99M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $812.57M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $835.74M 8-K · filed 2019-01-29 | |
| 2014-09-30 | $887.34M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $912.83M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $831.25M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $872.98M 10-K · filed 2017-03-01 | |
| 2013-09-30 | $867.93M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $312.48M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $319.78M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $178.89M 10-K · filed 2016-02-29 | |
| 2011-12-31 | $160.88M 10-K · filed 2015-02-27 | |
| 2010-12-31 | $23.05M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |